UnitedHealth tests AI system to streamline medical claims processing - Bloomberg
Investing.com - Truist Securities has raised its price target on Prologis (NYSE:PLD) to $131.00 from $120.00 while maintaining a Buy rating on the stock. The industrial REIT giant, with a market capitalization of $115.23 billion, is currently trading near its 52-week high of $125.05, having delivered an impressive 10.08% return in the past week.
The price target increase follows Prologis reporting third-quarter 2025 results that beat Truist’s expectations by $0.05 per share in normalized funds from operations (FFO).
Despite the earnings beat, Prologis only raised its full-year 2025 guidance by $0.02 per share at the midpoint, prompting Truist to make small adjustments to its normalized FFO estimates.
Truist increased its 2025 FFO estimates while slightly reducing its 2026 projections for the industrial real estate investment trust.
The firm cited "incrementally positive fundamental results/data" as driving recent stock price gains and stated there is "runway ahead of the stock," supporting its continued Buy rating.
In other recent news, ProLogis reported its third-quarter 2025 earnings, surpassing Wall Street expectations with an earnings per share of $0.82, compared to the forecasted $0.67. The company also exceeded revenue forecasts, reporting $2.05 billion against the expected $2.03 billion. This strong performance has been noted by analysts, leading to several adjustments in stock ratings and price targets. BMO Capital upgraded ProLogis from Underperform to Market Perform, citing a strategic shift in the company’s data center business. Freedom Capital Markets raised its price target for ProLogis to $134, maintaining a Buy rating, following the company’s record leasing activity and increased full-year forecast. Additionally, UBS increased its price target to $137, highlighting ProLogis’ advancements in industrial warehouse fundamentals and data center opportunities. These developments reflect a positive outlook from analysts on ProLogis’ future growth potential.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.